Iranian Red Crescent Medical Journal

Published by: Kowsar

Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Iranian Hospital Infections

Nastaran Fazeli 1 and Hassan Momtaz 1 , *
Authors Information
1 Department of Microbiology, Shahrekord Branch, Islamic Azad University, Shahrekord, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: October 01, 2014, 16 (10); e15722
  • Published Online: October 5, 2014
  • Article Type: Research Article
  • Received: October 28, 2013
  • Revised: December 25, 2013
  • Accepted: January 18, 2014
  • DOI: 10.5812/ircmj.15722

To Cite: Fazeli N, Momtaz H. Virulence Gene Profiles of Multidrug-Resistant Pseudomonas aeruginosa Isolated From Iranian Hospital Infections, Iran Red Crescent Med J. 2014 ; 16(10):e15722. doi: 10.5812/ircmj.15722.

Copyright © 2014, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006; 50(1): 43-8[DOI][PubMed]
  • 2. Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med. 2000; 160(4): 501-9[PubMed]
  • 3. Gad GF, El-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007; 60(5): 1010-7[DOI][PubMed]
  • 4. Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Expert Rev Pharmacoecon Outcomes Res. 2010; 10(4): 441-51[DOI][PubMed]
  • 5. Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis. 2000; 19(12): 915-25[PubMed]
  • 6. Mavrodi DV, Bonsall RF, Delaney SM, Soule MJ, Phillips G, Thomashow LS. Functional analysis of genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from Pseudomonas aeruginosa PAO1. J Bacteriol. 2001; 183(21): 6454-65[DOI][PubMed]
  • 7. Finnan S, Morrissey JP, O'Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004; 42(12): 5783-92[DOI][PubMed]
  • 8. Krall R, Schmidt G, Aktories K, Barbieri JT. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect Immun. 2000; 68(10): 6066-8[PubMed]
  • 9. Wieland CW, Siegmund B, Senaldi G, Vasil ML, Dinarello CA, Fantuzzi G. Pulmonary inflammation induced by Pseudomonas aeruginosa lipopolysaccharide, phospholipase C, and exotoxin A: role of interferon regulatory factor 1. Infect Immun. 2002; 70(3): 1352-8[PubMed]
  • 10. Shaver CM, Hauser AR. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung. Infect Immun. 2004; 72(12): 6969-77[DOI][PubMed]
  • 11. Lomholt JA, Poulsen K, Kilian M. Epidemic population structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has a distinct combination of virulence factors. Infect Immun. 2001; 69(10): 6284-95[DOI][PubMed]
  • 12. Makedou KG, Tsiakiri EP, Bisiklis AG, Chatzidimitriou M, Halvantzis AA, Ntoutsou K, et al. Changes in antibiotic resistance of the most common Gram-negative bacteria isolated in intensive care units. J Hosp Infect. 2005; 60(3): 245-8[DOI][PubMed]
  • 13. Tsukayama DT, van Loon HJ, Cartwright C, Chmielewski B, Fluit AC, van der Werken C, et al. The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial. Int J Antimicrob Agents. 2004; 24(4): 339-45[DOI][PubMed]
  • 14. Shahini N, Shahini N, Ala S. Determining of resistance and sensitivity of Pseudomonas aeruginosa in Iran in 2010-2011. Res Pharm Sci. 2012; 7(5)
  • 15. Akingbade O, Balogun S, Ojo D, Afolabi R, Motayo B, Okerentugba P, et al. Plasmid profile analysis of multidrug resistant Pseudomonas aeruginosa isolated from wound infections in South West, Nigeria. World Appl Sci J. 2012; 20(6): 766-75
  • 16. Oliver A, Weigel LM, Rasheed JK, McGowan Jr JJ, Raney P, Tenover FC. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli. Antimicrob Agents Chemother. 2002; 46(12): 3829-36[PubMed]
  • 17. Tokajian S, Timani R, Issa N, Araj G. Molecular Characterization, Multiple Drug Resistance, and Virulence Determinants of Pseudomonas aeruginosa Isolated from Lebanon. Br Microbiol Res J. 2012; 2(4): 243-50[DOI]
  • 18. Lim KT, Yasin RM, Yeo CC, Puthucheary SD, Balan G, Maning N, et al. Genetic fingerprinting and antimicrobial susceptibility profiles of Pseudomonas aeruginosa hospital isolates in Malaysia. J Microbiol Immunol Infect. 2009; 42(3): 197-209[PubMed]
  • 19. M100–S22 Performance standards for antimicrobial susceptibility testing 22nd informational supplement. 2012;
  • 20. Strateva T. Microbiological and molecular-genetic investigations on the resistance mechanisms and virulence factors in clinical strains of Pseudomonas aeruginosa. 2008;
  • 21. Wozniak DJ, Ohman DE. Transcriptional analysis of the Pseudomonas aeruginosa genes algR, algB, and algD reveals a hierarchy of alginate gene expression which is modulated by algT. J Bacteriol. 1994; 176(19): 6007-14[PubMed]
  • 22. Schurr MJ, Martin DW, Mudd MH, Deretic V. Gene cluster controlling conversion to alginate-overproducing phenotype in Pseudomonas aeruginosa: functional analysis in a heterologous host and role in the instability of mucoidy. J Bacteriol. 1994; 176(11): 3375-82[PubMed]
  • 23. Wolska K, Szweda P. Genetic features of clinical Pseudomonas aeruginosa strains. Pol J Microbiol. 2009; 58(3): 255-60[PubMed]
  • 24. Gorgani N, Ahlbrand S, Patterson A, Pourmand N. Detection of point mutations associated with antibiotic resistance in Pseudomonas aeruginosa. Int J Antimicrob Agents. 2009; 34(5): 414-8[DOI][PubMed]
  • 25. Zavascki AP, Barth AL, Fernandes JF, Moro AL, Goncalves AL, Goldani LZ. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study. Crit Care. 2006; 10(4)[DOI][PubMed]
  • 26. Zavascki AP, Gaspareto PB, Martins AF, Goncalves AL, Barth AL. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil. J Antimicrob Chemother. 2005; 56(6): 1148-51[DOI][PubMed]
  • 27. Lanini S, D'Arezzo S, Puro V, Martini L, Imperi F, Piselli P, et al. Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser. PLoS One. 2011; 6(2)[DOI][PubMed]
  • 28. Pitten FA, Panzig B, Schroder G, Tietze K, Kramer A. Transmission of a multiresistant Pseudomonas aeruginosa strain at a German University Hospital. J Hosp Infect. 2001; 47(2): 125-30[DOI][PubMed]
  • 29. West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA. 2002; 287(22): 2958-67[PubMed]
  • 30. Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL. Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis. 2008; 47(12): 1526-33[DOI][PubMed]
  • 31. Tingpej P, Smith L, Rose B, Zhu H, Conibear T, Al Nassafi K, et al. Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol. 2007; 45(6): 1697-704[DOI][PubMed]
  • 32. Viedma E, Juan C, Villa J, Barrado L, Orellana MA, Sanz F, et al. VIM-2-producing multidrug-resistant Pseudomonas aeruginosa ST175 clone, Spain. Emerg Infect Dis. 2012; 18(8): 1235-41[DOI][PubMed]
  • 33. Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med. 2008; 121(8): 702-8[DOI][PubMed]
  • 34. Khan JA, Iqbal Z, Rahman SU, Farzana K, Khan A. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. Pak J Pharm Sci. 2008; 21(3): 311-5[PubMed]
  • 35. Ranjan KP, Ranjan N, Bansal SK, Arora DR. Prevalence of Pseudomonas aeruginosa in post-operative wound infection in a referral hospital in Haryana, India. J Lab Physicians. 2010; 2(2): 74-7[DOI][PubMed]
  • 36. Burjanadze I, Kurtsikashvili G, Tsereteli D,, Tsertsvadze E, Kekelidze M, Imnadze P, et al. Pseudomonas aeruginosa infection in an intensive care unit. Int J Infect Control. 2007; 3(2): 1-3[DOI]
  • 37. Knudsen PK, Olesen HV, Hoiby N, Johannesson M, Karpati F, Laerum BN, et al. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros. 2009; 8(2): 135-42[DOI][PubMed]
  • 38. Savas L, Duran N, Savas N, Onlen Y, Ocak S. The prevalence and resistance patterns of Pseudomonas aeruginosa in intensive care units in a university hospital. Turk J Med Sci. 2005; 35(5): 317-22
  • 39. Public Health England . Voluntary surveillance of Pseudomonas spp. and Stenotrophomonas spp. causing bacteraemia in England, Wales and Northern Ireland. 2012;
  • 40. Tacconelli E, Tumbarello M, Bertagnolio S, Citton R, Spanu T, Fadda G, et al. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis. 2002; 8(2): 220-1[DOI][PubMed]
  • 41. Shahcheraghi F, Nikbin VS, Feizabadi MM. Prevalence of ESBLs genes among multidrug-resistant isolates of Pseudomonas aeruginosa isolated from patients in Tehran. Microb Drug Resist. 2009; 15(1): 37-9[DOI][PubMed]
  • 42. Rastegar Lari A, Bahrami Honar H, Alaghehbandan R. Pseudomonas infections in Tohid Burn Center, Iran. Burns. 1998; 24(7): 637-41[PubMed]
  • 43. Saderi H, Karimi Z, Owlia P, Bahar MA, Akhavi Rad SMB. Phenotypic detection of metallo-beta-lactamase producing Pseudomonas aeruginosa strains isolated from burned patients. Iran J Pathol. 2008; 3(1): 20-4
  • 44. Salimi H, Owlia P, Yakhchali B, Rastegar Lari AA. Characterization of Pseudomonas aeruginosa in burn patients using PCR-restriction fragment length polymorphism and random amplified polymorphic DNA analysis. Iran J Med Sci. 2010; 35(3): 236-41
  • 45. Moniri R, Mosayebi Z, Movahedian AH, Mousavi GA. Emergence of multi-drug-resistant Pseudomonas aeruginosa isolates in neonatal septicemia. J Infect Dis Antimicrob Agents. 2005; 22(2): 39-44
  • 46. Movahedi Z, Pourakbari B, Mahmoudi S, Sabouni F, Ashtiani Haghi MT, Hosseinpour Sadeghi R, et al. Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran. J Prev Med Hyg. 2013; 54(1): 24-8[PubMed]
  • 47. Mihani F, Khosravi A. Isolation Of Pseudomonas Aeruginosa Strains Producing Metallo Beta Lactamases From Infections In Burned Patients And Identification Of Bla Imp And Bla Vim Genes By Pcr. Iran J Med Microbiol. 2007;
  • 48. Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns. 2000; 26(8): 737-40[PubMed]
  • 49. Eftekhar F, Khodadad A, Henry D, Speert DP. Isolation and genetic fingerprinting of Pseudomonas aeruginosa from Iranian patients with cystic fibrosis using RAPDPCR. Iran J Biotechnol. 2003; 1(2): 95-100
  • 50. Ahangarzadeh Rezaee M, Behzadiyan Nejad Q, Owlia P, Najjar Pirayeh S. n vitro activity of imipenem and ceftazidime against mucoid and non-mucoid strains of Pseudomonas aeruginosa isolated from patients in Iran. Arch Iran Med. 2002; 5: 251-4
  • 51. Japoni A, Alborzi A, Kalani M, Nasiri J, Hayati M, Farshad S. Susceptibility patterns and cross-resistance of antibiotics against Pseudomonas aeruginosa isolated from burn patients in the South of Iran. Burns. 2006; 32(3): 343-7[DOI][PubMed]
  • 52. Shiny PA, Rajendran S, Sarayu YL. A comparative analysis of isolation and antibiotic sensitivity pattern of Pseudomonas aeruginosa isolated from pus and urine with special reference to phenotypic and genotypic expression of extended spectrum beta lactamases (ESBLs). J Acad Clin Microbiol . 2013; 15(1): 3-6[DOI]
  • 53. Sun Y, Karmakar M, Taylor PR, Rietsch A, Pearlman E. ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival. J Immunol. 2012; 188(4): 1884-95[DOI][PubMed]
  • 54. Fazeli H, Akbari R, Moghim S, Narimani T, Arabestani MR, Ghoddousi AR. Pseudomonas aeruginosa infections in patients, hospital means, and personnel's specimens. J Res Med Sci. 2012; 17(4): 332-7[PubMed]
  • 55. Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001; 32 Suppl 2-55[DOI][PubMed]
  • 56. Brown PD, Izundu A. Antibiotic resistance in clinical isolates of Pseudomonas aeruginosa in Jamaica. Rev Panam Salud Publica. 2004; 16(2): 125-30[PubMed]
  • 57. Bonfiglio G, Carciotto V, Russo G, Stefani S, Schito GC, Debbia E, et al. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J Antimicrob Chemother. 1998; 41(2): 307-10[PubMed]
  • 58. Bouza E, Garcia-Garrote F, Cercenado E, Marin M, Diaz MS. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group. Antimicrob Agents Chemother. 1999; 43(4): 981-2[PubMed]
  • 59. Smith S, Ganiyu O, John R, Fowora M, Akinsinde K, Odeigah P. Antimicrobial resistance and molecular typing of pseudomonas aeruginosa isolated from surgical wounds in Lagos, Nigeria. Acta Med Iran. 2012; 50(6): 433-8[PubMed]
  • 60. Du SJ, Kuo HC, Cheng CH, Fei ACY, Wei HW, Chang SK. Molecular mechanisms of ceftazidime resistance in Pseudomonas aeruginosa isolates from canine and human infections. Vet Med. 2010; 55(4): 172-82
  • 61. Yu WL, Chuang YC, Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect. 2006; 39(4): 264-77[PubMed]
  • 62. Olson JC, Fraylick JE, McGuffie EM, Dolan KM, Yahr TL, Frank DW, et al. Interruption of multiple cellular processes in HT-29 epithelial cells by Pseudomonas aeruginosa exoenzyme S. Infect Immun. 1999; 67(6): 2847-54[PubMed]
  • 63. Yahr TL, Goranson J, Frank DW. Exoenzyme S of Pseudomonas aeruginosa is secreted by a type III pathway. Mol Microbiol. 1996; 22(5): 991-1003[PubMed]
  • 64. Jabalameli F, Mirsalehian A, Khoramian B, Aligholi M, Khoramrooz SS, Asadollahi P, et al. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients. Burns. 2012; 38(8): 1192-7[DOI][PubMed]
  • 65. Terada LS, Johansen KA, Nowbar S, Vasil AI, Vasil ML. Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity. Infect Immun. 1999; 67(5): 2371-6[PubMed]
  • 66. Idris SN, Desa MN, Aziz MN, Taib NM. Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital. Southeast Asian J Trop Med Public Health. 2012; 43(1): 116-23[PubMed]
  • 67. Bradbury RS, Roddam LF, Merritt A, Reid DW, Champion AC. Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol. 2010; 59: 881-90[DOI][PubMed]
  • 68. Allydice-Francis K, Brown PD. Diversity of Antimicrobial Resistance and Virulence Determinants in Pseudomonas aeruginosa Associated with Fresh Vegetables. Int J Microbiol. 2012; 2012: 426241[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments